Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
Upinder Kaur, Kumudini Acharya, Ritwick Mondal, et al.
European Journal of Pharmacology (2020) Vol. 887, pp. 173545-173545
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese, Jessica Gambardella, Celestino Sardu, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 462-462
Open Access | Times Cited: 128
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
Jithin Kuriakose, Augusto C. Montezano, Rhian M. Touyz
Clinical Science (2021) Vol. 135, Iss. 2, pp. 387-407
Open Access | Times Cited: 51
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 32
Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19
Aisha Tabassum, Mohammad Shahid Iqbal, Sadia Sultan, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 28
Adverse events and breakthrough infections associated with COVID‐19 vaccination in the Indian population
Geetika Arora, Jyoti Taneja, Priya Bhardwaj, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3147-3154
Open Access | Times Cited: 28
Vitamin D as an Adjuvant Immune Enhancer to SARS-Cov-2 Vaccine
Azza Salamony, M. Abdel‐Salam, Nancy Elguindy, et al.
Current Microbiology (2025) Vol. 82, Iss. 3
Closed Access
Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
Martín Iglesias, Patricia Butrón, Iván Torre-Villalvazo, et al.
Aging and Disease (2021) Vol. 12, Iss. 2, pp. 360-360
Open Access | Times Cited: 37
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9309-9309
Open Access | Times Cited: 32
Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings
Mathias Haarhaus, Carla Santos-Araújo, Michael Haase, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. 3, pp. 805-813
Open Access | Times Cited: 31
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
Giovanni A. Rossi, Oliviero Sacco, Antonino Capizzi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon
Archives of Pharmacal Research (2021) Vol. 44, Iss. 5, pp. 499-513
Open Access | Times Cited: 26
Natural Products as a Potential Source of Promising Therapeutics for COVID‐19 and Viral Diseases
Soheila Bafandeh, Ehsaneh Khodadadi, Khudaverdi Ganbarov, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 10
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma
Marco Matucci-Cerinić, Michael Hughes, Gloria Taliani, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 10, pp. 102899-102899
Open Access | Times Cited: 22
Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India
Sankha Shubhra Chakrabarti, Upinder Kaur, Anup Singh, et al.
Aging and Disease (2020) Vol. 11, Iss. 6, pp. 1339-1339
Open Access | Times Cited: 21
COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach
Soha R. Abd El Hadi, Esmat E Zien El-Deen, Mostafa M. Bahaa, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3313-3330
Open Access | Times Cited: 14
Effect of Preexisting Asthma on the Risk of ICU Admission, Intubation, and Death from COVID-19: A Systematic Review and Meta-Analysis
Abhinav Bhattarai, Garima Dhakal, Sangam Shah, et al.
Interdisciplinary Perspectives on Infectious Diseases (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 9
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
Anindita Banerjee, Upasana Ganguly, Sarama Saha, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 19, Iss. 10, pp. 1245-1258
Open Access | Times Cited: 12
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas Patel
Therapeutic Advances in Drug Safety (2021) Vol. 12
Open Access | Times Cited: 12
Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences—a review
Payel Mal, Tuhin Mukherjee, Abhay Kumar Upadhyay, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 38, pp. 57040-57053
Open Access | Times Cited: 8
Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review
Z. Wang, Hongbing Fan, Jianping Wu
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 23, pp. 12896-12914
Open Access | Times Cited: 1
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, et al.
(2020)
Open Access | Times Cited: 11
SIT1 transporter as a potential novel target in treatment of COVID-19
Sabina Semiz
BioMolecular Concepts (2021) Vol. 12, Iss. 1, pp. 156-163
Open Access | Times Cited: 10
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Pandemic: Are Africa’s Prevalence and Mortality Rates Relatively Low?
Solomon H. Mariam
Advances in Virology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 7
Network Pharmacology Integrated Molecular Docking Reveals the Anti-COVID-19 and SARS Mechanism of Fufang Banlangen Keli
Li Cheng, Fei Wang, Shun Bo Zhang, et al.
Natural Product Communications (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top